Interviews
December 09, 2019
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
November 12, 2019
Vascular Disease Management talks with Ravish Sachar, MD, FACC, University of North Carolina - Rex Hospital Physician-in-Chief for Heart and Vascular Services, and Principal Investigator of the RANGER II SFA trial.
May 21, 2019
Bret N. Wiechmann, MD, discusses current options for treatment, his personal approach to treatment decisions, and upcoming technologies to watch.
December 14, 2018
In this interview, Dr. Schermerhorn discusses the results of the TCAR (Trans-Carotid Artery Revascularization) trial, which compared TCAR with CEA in patients with carotid stenosis.
August 28, 2018
Rachel Piechowiak, DO, discusses the implications of a US clinical trial which investigated the use of geniculate artery embolization for decreasing inflammation and pain in osteoarthritis-related knee pain by blocking abnormal blood vessels in the…
July 16, 2018
The results of a pilot study suggest that percutaneous CT-guided cryovagotomy is a safe and feasible procedure that may help patients with mild-to-moderate obesity lose weight. The procedure uses CT guidance and argon gas to freeze the posterior…
May 16, 2018
The recent publication of the landmark ATTRACT trial has offered important data on the treatment of acute deep vein thrombosis (DVT). Anthony Comerota, MD, is one of the authors of the paper, and he joined us to explain the findings of the trial…
March 16, 2017
VDM spoke with George Adams, MD, MHS, at the 43rd Annual VEITH Symposium regarding the ongoing DANCE and LIMBO trials.
February 10, 2017
An interview with the principal investigator of the ongoing DRASTICO trial, which is comparing drug-eluting stent vs drug-eluting balloon in complex patients.
December 29, 2016
Johannes Lammer, MD, is professor of radiology and interventional radiology at the Medical University of Vienna in Vienna, Austria. Dr. Lammer is principal investigator for the ESPRIT I trial, which evaluated the safety and performance of the ESPRIT…
December 05, 2016
At VEITH Symposium, Dr. Ansel shared new findings from subanalyses as well as 5-year results that show widening benefits from the drug-eluting stent.
Back to Top